RELIQ HEALTH TECHNOLOGIES IN (RHT.CA) Forecast, Price Target & Analyst Ratings

TSX-V:RHT • CA75955T1030

Current stock price

0.215 CAD
0 (0%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for RELIQ HEALTH TECHNOLOGIES IN (RHT.CA).

Forecast Snapshot

Consensus Price Target

Price Target
CA$1.79
+ 730.23% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q4 / 2023
EPS Estimate
CA$0.00
Revenue Estimate
4.959M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
84.44%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
CA$1.79
Upside
+ 730.23%
From current price of CA$0.22 to mean target of CA$1.79, Based on 9 analyst forecasts
Low
CA$1.77
Median
CA$1.79
High
CA$1.84

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

9 Wall Street analysts provided a forecast for the next 12 months for RHT.CA. The average price target is 1.79 CAD. This implies a price increase of 730.23% is expected in the next year compared to the current price of 0.215.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

RHT Current Analyst RatingRHT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

RHT Historical Analyst RatingsRHT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
84.44%
RHT.CA was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about RHT.CA.
In the previous month the buy percentage consensus was at a similar level.
RHT.CA was analyzed by 9 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q4 / 2023
EPS Estimate
CA$0.00
Revenue Estimate
4.959M
Revenue Q2Q
116.69%
EPS Q2Q
N/A
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2023 - 2025

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2020 2021 2022 2023 2024 2025
Revenue
YoY % growth
RHT.CA revenue by date.RHT.CA revenue by date.
1.143M
528.35%		1.462M
27.92%		8.552M
484.87%		17.661M
106.52%		35.221M
99.43%		99.879M
183.58%
EBITDA
YoY % growth
RHT.CA ebitda by date.RHT.CA ebitda by date.
-10.721M
15.67%		-11.501M
-7.28%		-8.18M
28.87%		447.947K
105.48%		6.135M
1,269.58%		32.209M
425.00%
EBIT
YoY % growth
RHT.CA ebit by date.RHT.CA ebit by date.
-11.166M
16.34%		-11.627M
-4.13%		-8.296M
28.65%		-3.09K
99.96%		5.99M
193,951.13%		32.069M
435.38%
Operating Margin
RHT.CA operating margin by date.RHT.CA operating margin by date.
-976.87%-795.19%-97.01%-0.02%17.01%32.11%
EPS
YoY % growth
RHT.CA eps by date.RHT.CA eps by date.
N/AN/AN/A0.010.03
200.00%		0.12
300.00%

All data in CAD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		0.000.000.000.010.020.030.030.03
200.00%		0.03
50.00%
Revenue
Q2Q % growth		4.959M
116.69%		5.011M
44.32%		5.857M
42.21%		7.468M
57.52%		16.887M
240.53%		20.231M
303.73%		24.328M
315.37%		25.68M
243.87%		29.64M
75.52%
EBITDA
Q2Q % growth		413.03K
134.74%		437.75K
162.53%		552.08K
991.71%		1.191M
74.89%		3.954M
857.32%		6.048M
1,281.61%		8.011M
1,351.06%		8.434M
608.14%		9.716M
145.73%
EBIT
Q2Q % growth		375.95K
128.82%		401.7K
155.19%		515K
7,740.95%		1.155M
94.02%		3.918M
942.16%		6.013M
1,396.89%		7.976M
1,448.74%		8.399M
627.19%		9.681M
147.09%

All data in CAD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

RHT.CA Yearly Revenue VS EstimatesRHT.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
RHT.CA Yearly EPS VS EstimatesRHT.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2023 2024 2025 0 0.05 -0.05 0.1

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
68.33%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
126.89%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
80.52%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

RELIQ HEALTH TECHNOLOGIES IN / RHT.CA Forecast FAQ

What do analysts expect the price target to be for RELIQ HEALTH TECHNOLOGIES IN (RHT.CA)?

9 analysts have analysed RHT.CA and the average price target is 1.79 CAD. This implies a price increase of 730.23% is expected in the next year compared to the current price of 0.215.

Can you provide the consensus estimates for RELIQ HEALTH TECHNOLOGIES IN next earnings?

The consensus EPS estimate for the next earnings of RELIQ HEALTH TECHNOLOGIES IN (RHT.CA) is 0 CAD and the consensus revenue estimate is 4.96M CAD.

What is the number of analysts for RHT stock?

The number of analysts covering RELIQ HEALTH TECHNOLOGIES IN (RHT.CA) is 9.